We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




CT-Equipped Ambulance Proves Vital for Early Treatment of Stroke Patients

By HospiMedica International staff writers
Posted on 12 Jun 2012
NeuroLogica Corporation (Danvers, MA, USA), a manufacturer of medical imaging equipment, and MEYTEC GmbH (MEYTEC; Werneuchen/Seefeld, Brandenburg, Germany), which specializes in telemedicine solutions, have announced the development of the world’s first comprehensive mobile stroke ambulance. More...


First conceived by the Charite-University Medicine Berlin, with the support of MEYTEC GmbH, the Stroke-Emergency-Mobile unit, VIMED STEMO, combines MEYTEC’s innovative telemedicine solutions with NeuroLogica’s state-of-the-art portable CT scanner, CereTom, a portable 8-slice CT scanner that delivers high-quality perfusion scans, allowing physicians onboard the ambulance to quickly evaluate, diagnose, and treat the patient within the first hour of stroke onset.

Utilizing 3G, 4G, and satellite technology, VIMED STEMO allows laboratory results, high-quality images, and care instruction to be transmitted to emergency rooms or trauma centers in real time, enabling patients to be treated faster as well as reducing possible disabilities resulting from stroke.

“With the technological solution realized in STEMO, we have got a fascinating mobile facility that has already proven its technological stability and clinical usefulness in hundreds of cases,” said Heinrich Audebert, professor, Charite-University Medicine and head, Stroke-Emergency-Mobile association. “Hyper-acute stroke care, including thrombolytic treatment before arrival at a hospital, has become reality in Berlin.”

David Webster, vice president, global sales and marketing, NeuroLogica, agrees that VIMED STEMO is critical for the early intervention and treatment of stroke.

“A large part of NeuroLogica’s vision is to deliver high quality imaging to people and places around the world that otherwise would not have access to this life saving technology,” said Mr. Webster. “The partnership between NeuroLogica and MEYTEC, resulting in the development of the comprehensive stroke ambulance, is a real-world fulfillment of that vision. NeuroLogica is delighted to be part of this groundbreaking advancement in rapid stroke diagnosis and treatment.”


Related Links:

NeuroLogica Corporation

MEYTEC GmbH



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Imaging Table
Stille imagiQ2
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.